Baird Raises Price Target for Medtronic to $109
ByAinvest
Wednesday, Nov 19, 2025 11:27 pm ET1min read
MDT--
Baird analyst David Rescott raised Medtronic's (MDT) price target to $109 from $103, maintaining a Neutral rating. The historical ratings have shown consistent increases in price targets from various analysts, reflecting steady confidence in the company's market performance. Medtronic develops and manufactures therapeutic medical devices for chronic diseases, with a portfolio including pacemakers, defibrillators, stents, insulin pumps, spinal fixation devices, and more. The average target price for Medtronic PLC is $105.20, with a high estimate of $120.00 and a low estimate of $81.00.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet